Abbott has launched a new inactivated quadrivalent vaccine for influenza offering protection against four virus strains in India. It is the only 0.5 ml quadrivalent flu vaccine in India that has been approved for use in children below three years. This particular type of vaccine provides good immune response with less side-effect. This is yet another significant step in Abbott's endeavour to protect as many people as possible against the flu.
Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.
